Pictet Asset Management Holding SA
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1993888
CAROUGE, V8
Position in SUPN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$20,114,551
-$3,185,440 QoQ
Shares Held
432,478
-4.1% QoQ
Ownership
0.744%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 331 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pictet Asset Management Holding SA holds $456,869,338 across 25 Drug Manufacturers - Specialty & Generic names. SUPN ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
267,852 | $145,130,249 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
430,635 | $72,579,222 | |
| 3 | ALKS |
Alkermes plc.
|
838,026 | $43,908,372 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
608,650 | $38,923,167 | |
| 5 | VTRS |
Viatris Inc
|
2,437,987 | $38,715,233 | |
| 6 | ZTS |
Zoetis Inc.
|
514,723 | $36,987,994 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
432,478 | $20,114,551 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
544,494 | $18,447,456 |
All Filings in SUPN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,114,551 | 432,478 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $23,299,991 | 450,764 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $24,024,930 | 483,399 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $24,321,525 | 508,925 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $17,477,272 | 554,482 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $17,813,150 | 543,913 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $19,029,272 | 526,252 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $17,479,352 | 560,595 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,602,798 | 545,899 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,770,127 | 990,036 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $30,273,613 | 1,046,082 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $25,379,618 | 920,552 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||